| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 5150 | [18F]Lansoprazole Precursor |
5150.0010: 10 mg per vial
Please inquire for customized filling and bulk quantities.
|
|
Precursor for [18F]Lansoprazole
|
||
| Molar Mass: 349.36 | ||
| C16H13F2N3O2S | ||
| [1613520-76-5] | ||
| Off-white to brownish solid packaged in dark glass screw cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H and 19F NMR spectra |
||
|
Chemical Name: CA index name: 1H-Benzimidazole, 2-[[[4-[(2,2-difluoroethenyl)oxy]-3-methyl-2-pyridinyl]methyl]sulfinyl]- |
||
|
Synonymes: 2-(((5-((2,2-difluorovinyl)oxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1Hbenzo[d]imidazole; 2-[4-(2,2-Difluoro-vinyloxy)-3-methyl-pyridin-2-ylmethanesulfinyl]-1H-benzoimidazole; [18F]LNS precursor |
||
|
Literature: Fawaz M. V. et al. High Affinity Radiopharmaceuticals Based upon Lansoprazole for PET Imaging of Aggregated Tau in Alzheimer's Disease and Progressive Supranuclear Palsy: Synthesis, Pre-clinical Evaluation and Lead Selection. ACS Chem. Neurosci. 2014, 5, 718-730. |
||
| date of product catalogue issue: 10 May 2017 | ||